Phase II Pancreatic Cancer Study

A Multi-Center Study of SM-88 in Subjects With Pancreatic Cancer

Conditions: Pancreatic Cancer; Metastatic, Previously Treated

Currently Enrolling Locations are Listed Below

Additional trial information can be found here.

Location Address
Virginia Mason Medical Center Seattle, WA 98101
Washington University Saint Louis, MO 63110
University of Rochester Medical Center Rochester, NY 14642
City of Hope Duarte, CA 91010
UCLA Santa Monica, CA 90404
H. Lee Moffitt Cancer Center Tampa, FL 33612
Sarcoma Oncology Research Center Santa Monica, CA 09403
The Ohio State University Columbus, OH 43210
Florida Hospital-Tampa Tampa, FL 33613
University Medical Center New Orleans, LA 70112
Highlands Oncology Group Fayetteville, AK 72703
Arizona Oncology Mesa, AZ 85206
Setauket Cancer Research Center East Setauket, NY 11733
Cancer Center of Central Connecticut - Southington Southington, CT 06489
Center for Cancer and Blood Disorders Fort Worth, TX 76104
New York Cancer and Blood Specialists - Eastchester Cancer Center Bronx, NY 10469
June E. Nylen Cancer Center Sioux City, IA 51101
Illinois Cancer Specialists Arlington Heights, IL 60005
Texas Oncology - Baylor Baylor, TX 75246
Texas Oncology - Tyler Tyler, TX 75702
Texas Oncology - PA Dallas, TX 75231
Nebraska Cancer Specialists Omaha, NE 68130
New York Oncology Hematology Albany, NY 12206
Virginia Cancer Specialists Fairfax, VA 22033
Karmanos Cancer Institute Detroit, MI 48201